Eight different poois of purified human mitochondrial and cytoplasmic isoenzymes of aspartate aminotransferase were prepared, to examine the effects of the following matrix variables: the matrix support material (bovine serum albumin and polyvinylpyrrolidone), endogenous pyridoxal concentration, and azide as an antimicrobial preservative. Storage temperatures of 25 and 37 #{176}C were used as a rapid and convenient means of accelerating the degradation process. Activity of the enzyme was measured with and without pyridoxal in the reaction solution. We found that the mitochondrial isoenzyme was consistently more labile than the cytoplasmic isoenzyme under identical storage Conditions. Both isoenzymes were more stable in matrixes containing bovine serum albumin than in those containing polyvinylpyrrolidone. No apparent difference in the stability of either isoenzyme was observed at matrix pyridoxal concentrations of 15 MmoI/L and 150 tmoI/L. Only the mitochondrial isoenzyme in matrixes containing bovine serum albumin and 15 tmol of pyridoxal per liter had increased activity (about 9%) when pyridoxal was added to the enzymatic reagent. The amount of activity in reconstituted specimens did not apparently change after 72 h at 4 #{176}C.
Eight different poois of purified human mitochondrial and cytoplasmic isoenzymes of aspartate aminotransferase were prepared, to examine the effects of the following matrix variables: the matrix support material (bovine serum albumin and polyvinylpyrrolidone), endogenous pyridoxal concentration, and azide as an antimicrobial preservative. Storage temperatures of 25 and 37 #{176}C were used as a rapid and convenient means of accelerating the degradation process. Activity of the enzyme was measured with and without pyridoxal in the reaction solution. We found that the mitochondrial isoenzyme was consistently more labile than the cytoplasmic isoenzyme under identical storage Conditions. Both isoenzymes were more stable in matrixes containing bovine serum albumin than in those containing polyvinylpyrrolidone. No apparent difference in the stability of either isoenzyme was observed at matrix pyridoxal concentrations of 15 MmoI/L and 150 tmoI/L. Only the mitochondrial isoenzyme in matrixes containing bovine serum albumin and 15 tmol of pyridoxal per liter had increased activity (about 9%) when pyridoxal was added to the enzymatic reagent. The amount of activity in reconstituted specimens did not apparently change after 72 h at 4 #{176}C. (10, (12) (13) (14) (15) reported on a similar study (1) in which we used purified human cytoplasmic AST in a matrix containing bovine serum albumin (BSA). Although our materials were suitable for their intended use, their activity increased 20% when pyridoxal was added to our reagent. In addition, after the reconstituted specimens were stored for several days at 4 #{176}C, they became visibly turbid, and AST activities gradually increased in measurements performed without cofactor in the reagent.
AST activity in human serum is derived from two major isoenzymes, of cytoplasmic and mitochondrial origin (18) (19) (20) , which have been previously purified in our laboratory (1, 18 Table 1 . AST was routinely measured in single determinations on two different specimens from the same pool and storage history, with and without pyridoxal in the reaction mixture. Lyophilized specimens were reconstituted with distilled water, and measurements were performed within 1 to 8 h unless otherwise stated.
Isoenzyme preparations.
Cytoplasmic AST was purified from human erythrocytes by the procedure of Rej et al. (16) as adapted in our laboratory (1, 17) . Mitochondrial AST was purified from human liver as detailed previously (18) . The final specific activities of the preparations containing the cytoplasmic and mitochondrial isoenzymes were 81 and 138 U/L, respectively. Each preparation was subjected to polyacrylamide disc gel electrophoresis and developed for AST activity and protein according to techniques described pre- 17) . Only one band of AST formed for each preparation, with the cytoplasmic isoenzyme migrating substantially further towards the anode than the mitochondrial isoenzyme. Similarly, gels developed for protein showed only one band for the mitochondrial isoenzyme and one major band and two minor bands for the cytoplasmic isoenzyme. Pool preparation. 
Results and Discussion
Criteria used in selecting the matrix variables and concentrations listed in Table 2 were largely based on the composition of several materials used in two previously reported interlaboratory studies of AST (1, 6). The materials prepared for both studies contained only the purified cytoplasmic isoenzyme of AST. In one study (1), we reported using AST from either human erythrocytes or porcine heart in a matrix of BSA (30 g/L) and pyridoxal (15 mol/L (24) . Figure 1 shows the stability of the cytoplasmic isoenzyme of AST in four different matrixes with pyridoxal concentration of 15 molIL. All AST measurements shown were made with pyridoxal in the reagent. At a storage temperature of 37 #{176}C the isoenzyme appeared to be inactivated more rapidly in matrixes containing PVP than in those containing BSA. The accelerated inactivation in PVP appeared to coincide with a visible loss of structural integrity and the eventual collapse of the lyophilized matrix, which occurred in the individual vials after several weeks at 37 #{176}C. After this time, matrixes containing PVP were considerably more difficult to reconstitute than were the corresponding BSA matrixes, which showed no visible changes in structure. Adding aside to the PVP matrix appeared further to accelerate the loss of AST activity at 25 and 37 #{176}C, whereas no appreciable effect was observed in the BSA matrixes. At a storage temperature of 4 #{176}C, the pools shown in Figure 1 showed no appreciable change in AST activity after 39 days. Rej et al. (6) reported that lyophilized specimens stored at 4 #{176}C in a PVP matrix analogous to one shown in Plot 4 of Figure 1 retained their original activity after three years.
To depict the changes in AST activity as a consequence of ,storage in the different matrixes, Table 3 There are only minor differences, which we attribute to analytical variability, between individual values in Table 3 measured with and without pyridoxal in the reagent.
A comparison of matrixes which differ only with respect to the concentration of pyridoxal (e.g., PVP, no aside, storage temperature 37 #{176}C) indicates that 150 imol of cofactor per liter offers no greater protection than does 15 tmolIL. Of the matrixes tested, those containing azide in PVP appeared to be the most detrimental for the isoenzyme, as verified in Figure 1 . Storing the reconstituted specimens for three days appeared to affect negligibly the measured activity and was independent of azide, pyridoxal concentration in the matrix, and previous storage conditions.
Mean values (and SD) for all eight pools stored at 4 #{176}C for 39 days and then reconstituted and stored for three days were 50.6 (±2.33) U/L without pyridoxal and 51.8 (±2.08) U/L with pyridoxal in the reagent. These values were not significantly different by Student's -test (a = 0.05) from either the means of the freshly reconstituted pools stored at 4 #{176}C for 39 days or the means of the pools measured the day after they were lyophilized. In addition, on inspecting specimens from each of the pools three days after reconstitution, we saw no detectable turbidity. These results suggest that the cytoplasmic isoenzyme (or that portion that retains its activity) is saturated with pyridoxal in the lyophilized and reconstituted states in each of the matrixes examined. However, it does not exclude the possibility that structural changes in the cofactor bound covalently or in the proximity of the enzyme in the lyophilized material may cause the loss of enzyme activity when the specimens are stored.
The characteristics of the cytoplasmic isoenzyme in the materials described above differ markedly from those we described in a previous report (1). More specifically, we previously observed a 20% increase in activity when pyridoxal (120 tmolIL) was added to the AST reagent in freshly re-
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Pyrldoxal Finally, the previously described materials were clear after they were reconstituted, but slowly developed turbidity after several days of storage. Although the source of the enzyme and the composition of the matrix were essentially identical to those in the first pool listed in Table 3 (cytoplasmic AST from present in the other specimens was not added to the materials prepared for the study reported on here. Although we suspect that the glycerol is responsible for the anomalous effects, its role has not been formally established. Figure 2 shows the effects of storage on the human mitochondrial isoenzyme in matrixes, under conditions analogous to those for the cytoplasmic isoenzyme.
When the effects of the large-molecular-weight components of the matrixes were compared, those containing BSA again protected the enzyme substantially better than did those containing PVP; however, with the former there were apparent losses of AST activity even at a storage temperature of 4 #{176}C. n matrixes containing PVP, the isoenzyme lost most of its activity within a week of storage at 25 or 37 #{176}C, and then activity appeared to plateau Figure 2 shows that all of the matrixes containing pyridoxal gradually lost activity when stored at 4 #{176}C, the two pools containing BSA (15 zmol of pyridoxal per liter, with and without aside) showed a greater loss of AST activity when measured without pyridoxal in the reagent. After 39 days at 4 #{176}C (Table 4) , both pools had a difference in activity of 11 U/L between the values measured with and without pyridoxal in the reagent. These results indicate that the mitochondrial isoenzyme did not remain fully saturated with cofactor in these two matrixes. In contrast, the same isoenzyme stored at 4 #{176}C in the matrix containing PVP and 15 imol of pyridoxal per liter, without azide, lost essentially the same amount of activity as the comparable matrix containing BSA but showed no increase in activity when pyridoxal was added to the reagent. Furthermore, matrixes stored at 4 #{176}C and containing 150 imol of pyridoxal per liter in BSA (with and without azide) and in PVP (without azide) lost only minor amounts of AST activity and did not increase in activity with pyridoxal in the reagent. However, the increased matrix pyridoxal concentration did not appear to .confer any added stability at increased storage temperatures or to deter the deleterious effects of aside in PVP. When the activity in these materials was measured three days after they were reconstituted, essentially the same values were obtained as those for freshly reconstituted specimens. As was true for the cytoplasmic specimens, the reconstituted specimens were not visibly turbid after three days.
In summary, the human cytoplasmic isoenzyme appears to be substantially more stable than the mitochondrial isoenzynie in lyophilized materials of comparable composition. The large-molecular-weight component of the matrix apparently exerted the largest single effect on the stability of both iso- On the basis of both the results of this study and of our previous interlaboratory AST study (1) , we have prepared additional lyophilized materials containing the cytoplasmic isoenzyme of AST purified from human erythrocytes in a matrix of, per liter: 15 tmol of pyridoxal, 50 zmol of 2-oxoglutarate, 50 tmol of dithiothreitol, 50 mmol of Tris.HC1 buffer (pH 7.5), and no preservative. These materials have been extensively characterized in terms of the purified isoenzyme, stability in the lyophilized and reconstituted states, contaminating enzymes, among-vial variability, and assigned target values with the recently published IFCC method for measuring AST. Because we prepared only a few vials of each pool, these materials will be used primarily to assess the transferability of nationally or internationally endorsed methods for quantitating AST. More specifically, we are currently examining the interlaboratory performance of the recently proposed IFCC reference method for measuring AST
(22).
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